Bill > HB1099

This bill amends existing South Dakota law to reclassify a specific form of psilocybin, a psychoactive compound found in certain mushrooms, from a Schedule I controlled substance to a Schedule IV controlled substance. Schedule I substances are considered to have a high potential for abuse and no currently accepted medical use, while Schedule IV substances have a lower potential for abuse and a currently accepted medical use with limited risk of dependence. The bill specifically targets "the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the United States Food and Drug Administration," meaning this reclassification only applies to psilocybin that has undergone FDA approval as a medication. This change is made by adding this specific pharmaceutical composition to the list of substances classified under Schedule IV in South Dakota law, while psilocybin in other forms remains a Schedule I controlled substance.

Health and Social Services

https://sdlegislature.gov/#/Session/Bill/26592